Kai-Cheng Hsu: Our groundbreaking research on the ‘Utility of polygenic scores across diverse diseases in a hospital cohort for predictive modeling

Kai-Cheng Hsu, Chief Medical Officer of Biomedical Technology and Device Research Laboratories in Industrial Technology Research Institute, shared a post on LinkedIn:

“l am thrilled to announce that our groundbreaking research on the ‘Utility of polygenic scores across diverse diseases in a hospital cohort for predictive modeling’ has been published in Nature Communications! This pioneering study unlocks potential in precision medicine by showcasing how polygenic scores can dramatically enhance disease prediction and patient care strategies. A true milestone for our team, this publication underscores our commitment to revolutionizing healthcare through science.”

Additonal information.
Source: Kai Cheng Hsu/LinkedIn